An observational study in Reverse Total Shoulder Arthroplasty, sponsored by Bürgerspital Solothurn. Completed at 1 site in Switzerland. Open to participants aged 83 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-19.
Sponsored by Bürgerspital Solothurn · Observational
Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.
This is a retrospective single institution study. All patients older than 83 years who received a reverse shoulder arthroplasty from 2008 until 2019 are included. Elective cases are compared to fracture cases (patient demographics, length of hospital stay, complication rate, functional outcome, patient reported outcome scores and mortality).
Bürgerspital Solothurn is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who have already exceeded their life-expectancy (83 years in Switzerland)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients, who received a RTSA for degenerative reasons like cuff arthropathy or osteoarthritis
Procedure: Reverse Total Shoulder Arthroplasty (RTSA)
Patients, who received a RTSA for a proximal humerus fracture
Procedure: Reverse Total Shoulder Arthroplasty (RTSA)
Implantation of a Reverse Total Shoulder Arthroplasty
Patient reported outcome score: ASES
American Shoulder and Elbow Society (ASES) Score
Time frame: until august 2020
Complication rate
postoperative complications requiring surgical intervention
Time frame: until august 2020
Quality adjusted life year (QALY)
The quality adjusted life year (QALY) ) is a well-established indicator of the life quality for the remaining years and was calculated as the years of life following the operation, multiplied by the utility value, for the current study, defined as the postoperative American Shoulder and Elbow Surgeons Shoulder Score (ASES) score (0-1 points) at last follow-up.
Time frame: until august 2020
Mortality
Survivership
Time frame: until august 2020
Patient reported outcome score: QuickDASH
Quick Disabilities of the arm, shoulder and hand (DASH) Score,
Time frame: until august 2020
Patient reported outcome score: VAS
Visual analog score (VAS)
Time frame: until august 2020
Patient demographics
male/female ratio, age, BMI, ASA (American Society of Anesthesiologists) classification, hospital stay length, range of motion
Time frame: at time of surgery
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2019 to primary completion in Aug 2020, 16 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bürgerspital Solothurn